Fluorescent in-situ hybridization (FISH) for BCR/ABL in chronic myeloid leukemia after bone marrow transplantation
Keywords:
BCR/ABL Genes, Chronic myeloid leukemia, Fluorescent in-situ hybridizationAbstract
CONTEXT: Identification of Philadelphia chromosome or BCR/ABL gene rearrangement in chronic myeloid leukemia is important at diagnosis as well as after treatment. OBJECTIVE: To compare the results of karyotyping using fluorescent in-situ hybridization (FISH) upon diagnosis and 1 year after bone marrow transplantation in 12 patients. TYPE OF STUDY: Diagnostic test and residual disease detection. SETTING: Hematology and Hemotherapy Department, Federal University of São Paulo/Escola Paulista de Medicina, São Paulo, Brazil. SAMPLE: 12 patients with chronic myeloid leukemia at diagnosis and 1 year after bone marrow transplantation. DIAGNOSTIC TEST: Karyotyping was done in the usual way and the BCR/ABL gene-specific probe was used for FISH. MAIN MEASUREMENTS: Disease at diagnosis and residual. RESULTS: At diagnosis, 10 patients presented t(9;22)(q34.1;q11) as well as positive FISH. Two cases did not have metaphases but FISH was positive. After bone marrow transplantation, 8 patients presented normal karyotype, 1 had persistence of identifiable Philadelphia chromosome and 3 had no metaphases. Two cases showed complete chimera and 2 had donor and host cells simultaneously. FISH was possible in all cases after bone marrow transplantation and confirmed the persistence of identifiable Philadelphia chromosome clone in one patient, and identified another that did not present metaphases for analysis. Cases that showed mixed chimera in karyotype were negative for BCR/ABL by FISH. CONCLUSION: The applicability of FISH is clear, particularly for residual disease detection. Classical and molecular cytogenetics are complementary methods.
Downloads
References
Nowell PC, Hungerford BA. A minute chromosome in human granulocytic leukemia and lymphoma. Science 1960;132:1497.
Rowley JD. A new consistent chromosomal abnormality in CML. Nature (London) 1973;243:290-3.
Verfaillie CM. Biology of chronic myeloid leukemia. Hematol Oncol of N Am 1998;12(1):1-29.
Kartarjian HM, Giles FJ, O’Brien SM, Talpaz M. Clinical course and therapy of CML with interferon-alpha and chemotherapy. Hematol Oncol of N Am 1998;12(1):31-80.
McGlave P. Unrelated donor transplant therapy for CML. Hematol Oncol of N Am 1998;12(1):93-105.
Mittelman F, Karger S, editors. ISCN-1995: an international system for human cytogenetics nomenclature. Basel; 1995.
Chauffaille MLLF; Perroud PR, Catelani ALM, Obelar MRE, Kusagari N, Abe KT. LMC com cromossomo Philadelphia variante: relato de 3 casos. Newslab 1999;7(37):58-60.
Oliveira JSR, Chauffaille, MLLF, Colleoni GWB, et al. Granulocytic sarcoma presented as a reactivation of CML after allogeneic marrow transplantation. SP Med Jour 1998;116(2):1689-91.
Acar H, Stewart J, Connor MJ. Philadelphia chromosome in CML: confirmation of cytogenetic diagnosis in Ph+ and negative cases by FISH. Cancer Genet Cytogenet 1997;94:75-8.
Chauffaille MLF, Giglio A, Pinczowski P, et al. Monitorização de doença residual através de FISH em 2 pacientes com LMC pós alo TMO. Belo Horizonte: Anais XVI Congresso do Colégio Brasileiro de Hematologia; 1997:310.
Nagler A, Slavin S, Yarkoni S, Feijgin M, Amiel A. Detection of minimal residual disease after sex mismatch in BMT in CML by FISH. Cancer Genet Cytogenet 1994;73:130-3.
Polka G, Stuppia L, Bartolomeo PD, et al. FISH detection of mixed chimerism in 33 patients submitted to BMT. Bone Mar- row Transp 1996;17:231-6.
Bentz M, Cabot G, Moos M, et al. Detection of chimeric BCR/ ABL genes on BM samples and blood smears in CML and ALL by ISH. Blood 1994;83(7):1922-28.
